35356-0755 Ondansetron

Product NDC:

35356-0755

Brand Name:

Ondansetron

Generic Name:

Ondansetron

Dosage Form Name:

TABLET, ORALLY DISINTEGRATING

Administration Route:

Oral

Substances:

Name: Ondansetron

Strength: 4.0

Unit: mg/1

Packages:

Code: 35356-0755-65

Description: 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (35356-755-65)

Effective Date: Aug. 31, 2007

Discontinued: Oct. 11, 2019

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox